Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis.

Jeong, Joonho; Shin, Jung Woo; Jung, Seok Won; Park, Eun Ji; Park, Neung Hwa

Jeong, Joonho; Shin, Jung Woo; Jung, Seok Won; Park, Eun Ji; Park, Neung Hwa.

Afiliação

Jeong J; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Shin JW; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Jung SW; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Park EJ; Big-data Center, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Park NH; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

Clin Mol Hepatol ; 28(2): 254-264, 2022 04.

Article em En | MEDLINE | ID: mdl-34959261

Assuntos

Hepatite B Crônica; Adenina/uso terapêutico; Alanina/uso terapêutico; Colesterol; Hepatite B Crônica/tratamento farmacológico; Humanos; Pontuação de Propensão; Tenofovir/análogos & derivados; Tenofovir/uso terapêutico

Palavras-chave

Chronic hepatitis B; Dyslipidemia; Non-HBV infected control; Tenofovir alafenamide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Limite: Humans Idioma: En Revista: Clin Mol Hepatol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google